Norvax AS current engagements:

Stakeholders

  • Norsk Vaksinefabrikk Team
  • SINTEF Strategic R&D Partner
  • Strategic Technology Vendors and Partners; AFRY, Cytiva, Emtunga, IQVIA, Merck, Syntegon, Watson-Marlow, WSP
  • Borgeskogen 65 factory lease by Amentum and Kvadratera
  • mRNA UCV Consortium by NORVAX UK (ECAM Vaccines Limited)
  • Private Investors

Support by Norwegian Government Organizations

Pharmaceutical Industry Membership

Legal, Bank, Audit, Public Relations

NOT AN OFFER TO INVEST.
SEE RED HERRING DISCLAIMER.

Our Purpose. Our Process. Our Results.